Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,128 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $381.87 | 13 | $0 (2024) |
| Lilly USA, LLC | $149.45 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $99.66 | 4 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $94.67 | 4 | $0 (2024) |
| Harmony Biosciences Llc | $83.40 | 2 | $0 (2024) |
| Novo Nordisk Inc | $60.33 | 3 | $0 (2024) |
| PFIZER INC. | $54.72 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $45.68 | 2 | $0 (2024) |
| Lundbeck LLC | $45.25 | 2 | $0 (2024) |
| Corium, LLC | $39.91 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,063 | 44 | ABBVIE INC. ($381.87) |
| 2023 | $16.99 | 1 | Janssen Pharmaceuticals, Inc ($16.99) |
| 2022 | $48.31 | 1 | AstraZeneca Pharmaceuticals LP ($48.31) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $38.40 | General |
| Category: Narcoplepsy | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: PAIN | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: PAIN | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $121.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.55 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $45.00 | General |
| Category: Narcoplepsy | ||||||
| 10/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Endocrinology | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Obesity | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Neuroscience | ||||||
| 08/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 46 | 68 | $13,260 | $5,648 |
| 2022 | 7 | 282 | 692 | $121,880 | $47,989 |
| 2021 | 13 | 1,118 | 1,284 | $280,727 | $95,634 |
| 2020 | 7 | 531 | 567 | $105,220 | $33,809 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 46 | 68 | $13,260 | $5,648 | 42.6% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 71 | 299 | $43,355 | $17,739 | 40.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 37 | 58 | $24,360 | $10,976 | 45.1% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 57 | 121 | $24,200 | $9,138 | 37.8% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 53 | 149 | $13,410 | $5,164 | 38.5% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 27 | 28 | $8,120 | $2,252 | 27.7% |
| 99354 | Extended office or other outpatient service, first hour | Office | 2022 | 20 | 20 | $4,950 | $1,560 | 31.5% |
| 99326 | New patient custodial care facility, group care, or assisted living visit, typically 45 minutes | Office | 2022 | 17 | 17 | $3,485 | $1,160 | 33.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 284 | 347 | $101,671 | $38,130 | 37.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 296 | 377 | $82,648 | $22,062 | 26.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 134 | 134 | $51,590 | $15,334 | 29.7% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 33 | 36 | $11,880 | $4,988 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 85 | 103 | $15,403 | $4,963 | 32.2% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 71 | 71 | $4,828 | $4,650 | 96.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 21 | 21 | $4,809 | $2,638 | 54.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 82 | 82 | $3,116 | $1,377 | 44.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 28 | 28 | $1,064 | $475.78 | 44.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 18 | $1,638 | $467.52 | 28.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 34 | 34 | $1,496 | $277.02 | 18.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 11 | 11 | $429.00 | $222.03 | 51.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 22 | 22 | $155.00 | $49.50 | 31.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 230 | 258 | $56,672 | $18,239 | 32.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 53 | 53 | $20,405 | $5,333 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 96 | 103 | $15,450 | $5,028 | 32.5% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 22 | 23 | $7,590 | $2,963 | 39.0% |
About Brooke Ashley, NP
Brooke Ashley, NP is a Registered Nurse healthcare provider based in Harrisonburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2016. The National Provider Identifier (NPI) number assigned to this provider is 1750831731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brooke Ashley, NP has received a total of $1,128 in payments from pharmaceutical and medical device companies, with $1,063 received in 2024. These payments were reported across 46 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,128).
As a Medicare-enrolled provider, Ashley has provided services to 1,977 Medicare beneficiaries, totaling 2,611 services with total Medicare billing of $183,080. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Acute Care
- Location Harrisonburg, VA
- Active Since 10/13/2016
- Last Updated 08/03/2020
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1750831731
Products in Payments
- UBRELVY (Drug) $140.98
- RINVOQ (Biological) $121.34
- CAPLYTA (Drug) $94.67
- MOUNJARO (Drug) $83.68
- WAKIX (Drug) $83.40
- NURTEC ODT (Drug) $54.72
- QULIPTA (Drug) $50.93
- ANDEXXA (Biological) $48.31
- REXULTI (Drug) $45.68
- VYEPTI (Biological) $45.25
- EMGALITY (Drug) $41.92
- Azstarys (Drug) $39.91
- VRAYLAR (Drug) $38.37
- AIRSUPRA (Drug) $32.31
- BOTOX (Biological) $30.25
- Wegovy (Drug) $24.91
- Dexcom G6 Transmitter (Medical Supply) $24.58
- JARDIANCE (Drug) $23.85
- Ozempic (Drug) $21.04
- BREZTRI (Drug) $19.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Harrisonburg
Ms. Lisa Landes, Rn, Msn, Fnp, RN, MSN, FNP
Registered Nurse
Christopher Moore, Msn, Rn, Fnp, MSN, RN, FNP
Registered Nurse
Mrs. Kristen Kirwan, Fnp-Bc, FNP-BC
Registered Nurse
Amy Chico
Registered Nurse
Elijah Boothe, Fnp-C, FNP-C
Registered Nurse
Rachel Van Orden, M.s., Rn, Ccc-Slp, M.S., RN, CCC-SLP
Registered Nurse